ENVARSUS 1 mg, extended-release tablet 30 tablets
Active ingredients: Tacrolimus, Tacrolimus hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ENVARSUS 1 mg, comprimé à libération prolongée
- Pharmaceutical form
- comprimé à libération prolongée
- Route of administration
- orale
- Presentation description
- 3 plaquette(s) thermoformée(s) PVC de 10 comprimé(s)
- Marketing authorisation holder
- CHIESI FARMACEUTICI
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Aug 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69590806CIP73000122CIP133400930001226Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TACROLIMUScomprimé | 1 mg · un comprimé | FT |
| TACROLIMUS MONOHYDRATÉcomprimé | 1,02 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.